Filing Details
SUTRO BIOPHARMA, INC. (NASDAQ:STRO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:STRO
SUTRO BIOPHARMA, INC. (STRO) Files Quarterly Report for Q0
SUTRO BIOPHARMA, INC. (NASDAQ:STRO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
At publication ·
What changed
SUTRO BIOPHARMA, INC. (NASDAQ:STRO) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Sutro Biopharma (NASDAQ: STRO) filed its quarterly report (Form 10-Q) on August 12, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $21.30 with a market capitalization of $83.5 million.
- The 10-Q filing contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing, though with less detail than the annual 10-K report.
Market Context
SUTRO BIOPHARMA, INC.'s stock currently trades at $21.30 with a market capitalization of $83.5M.
The 10-Q provides SUTRO BIOPHARMA, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for SUTRO BIOPHARMA, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View STRO Stock Page
Frequently Asked Questions
Where can I read STRO's SEC filings?
Browse all filings on our STRO SEC filings page.
What types of SEC filings does SUTRO BIOPHARMA, INC. file?
Public companies like SUTRO BIOPHARMA, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.